BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esteves E, Rosa N, Correia MJ, Arrais JP, Barros M. New Targets for Zika Virus Determined by Human-Viral Interactomic: A Bioinformatics Approach. Biomed Res Int 2017;2017:1734151. [PMID: 29379794 DOI: 10.1155/2017/1734151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee HN, Manangeeswaran M, Lewkowicz AP, Engel K, Chowdhury M, Garige M, Eckhaus MA, Sourbier C, Ireland DD, Verthelyi D. NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice. JCI Insight 2022;7:e151420. [PMID: 35132958 DOI: 10.1172/jci.insight.151420] [Reference Citation Analysis]
2 Moura LM, Ferreira VLR, Loureiro RM, de Paiva JPQ, Rosa-Ribeiro R, Amaro E Jr, Soares MBP, Machado BS. The Neurobiology of Zika Virus: New Models, New Challenges. Front Neurosci 2021;15:654078. [PMID: 33897363 DOI: 10.3389/fnins.2021.654078] [Reference Citation Analysis]
3 Gratton R, Agrelli A, Tricarico PM, Brandão L, Crovella S. Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication. Int J Mol Sci 2019;20:E1048. [PMID: 30823365 DOI: 10.3390/ijms20051048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
4 Han Y, Mesplède T. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update. Expert Opin Investig Drugs 2018;27:951-62. [PMID: 30430882 DOI: 10.1080/13543784.2018.1548609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
5 Zou M, Liu H, Li J, Yao X, Chen Y, Ke C, Liu S. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection. Biochem Pharmacol 2020;177:113962. [PMID: 32272109 DOI: 10.1016/j.bcp.2020.113962] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
6 Fanunza E, Grandi N, Quartu M, Carletti F, Ermellino L, Milia J, Corona A, Capobianchi MR, Ippolito G, Tramontano E. INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation. Viruses 2021;13:2448. [PMID: 34960717 DOI: 10.3390/v13122448] [Reference Citation Analysis]
7 Villazana-Kretzer DL, Wuertz KM, Newhouse D, Damicis JR, Dornisch EM, Voss KM, Muruato AE, Paymaster JA, Schmiedecke SS, Edwards SM, Napolitano PG, Tisoncik-Go J, Ieronimakis N, Gale M Jr. ZIKV can infect human term placentas in the absence of maternal factors. Commun Biol 2022;5:243. [PMID: 35304593 DOI: 10.1038/s42003-022-03158-6] [Reference Citation Analysis]
8 Pitta JLLP, Vasconcelos CRDS, Wallau GDL, Campos TL, Rezende AM. In silico predictions of protein interactions between Zika virus and human host. PeerJ 2021;9:e11770. [PMID: 34513323 DOI: 10.7717/peerj.11770] [Reference Citation Analysis]
9 Lingel A, Lin H, Gavriel Y, Weaver E, Polepole P, Lopez V, Lei Y, Petro TM, Solomon B, Zhang C, Zhang L. Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains. J Biol Chem 2020;295:17114-27. [PMID: 33028637 DOI: 10.1074/jbc.RA120.015165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Rosa N, Campos B, Esteves AC, Duarte AS, Correia MJ, Silva RM, Barros M. Tracking the functional meaning of the human oral-microbiome protein-protein interactions. Adv Protein Chem Struct Biol 2020;121:199-235. [PMID: 32312422 DOI: 10.1016/bs.apcsb.2019.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]